Home › Funds › Private Harbour Investment Management & Counsel, LLC › ABT

Private Harbour Investment Management & Counsel, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Private Harbour Investment Management & Counsel, LLC reported holding 12,402 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$1.2M, representing 1.30% of its reported portfolio and ranking #20 among its reported holdings. Private Harbour Investment Management & Counsel, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)12.40K sh
Reported value held$1.23M
Portfolio Weight1.30%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Private Harbour Investment Management & Counsel, LLC's ABT position evolved

Private Harbour Investment Management & Counsel, LLC first disclosed a stake in ABT in Q3 2023 at 16,215 shares (US$1.6M). The position peaked in Q2 2025 at 13,878 shares, worth US$1.9M. Across 13 filings, Private Harbour Investment Management & Counsel, LLC increased the stake 0 time(s), trimmed it 7 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 12,402 shares valued at US$1.2M — a reduction of -415 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 16.21K $1.57M New
Q4 2023 15.57K $1.71M Reduce
Q1 2024 15.44K $1.75M Reduce
Q2 2024 15.40K $1.60M Hold
Q3 2024 15.36K $1.75M Hold
Q4 2024 14.69K $1.66M Reduce
Q1 2025 14.10K $1.87M Reduce
Q2 2025 13.88K $1.89M Reduce
Q3 2025 12.86K $1.72M Reduce
Q4 2025 12.82K $1.61M Hold
Q1 2026 12.79K $1.31M Hold
Q2 2026 12.82K $1.16M Hold
Q3 2026 12.40K $1.23M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Private Harbour Investment Management & Counsel, LLC held ABT?

Private Harbour Investment Management & Counsel, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Private Harbour Investment Management & Counsel, LLC's current position in ABT?

As of Q3 2026, Private Harbour Investment Management & Counsel, LLC holds 12.40K shares of ABT (ABBOTT LABORATORIES), valued at $1.23M, representing 1.30% of its reported portfolio and ranking #20.

Has Private Harbour Investment Management & Counsel, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Private Harbour Investment Management & Counsel, LLC reduced its position in ABT. The position peaked in Q2 2025 at 13.88K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.